The healthcare operator posted robust year-on-year and sequential growth across all key financial metrics.
Revenue rose 20.3% YoY to ₹1,643.79 crore, compared with ₹1,366.68 crore in the same quarter last year. It also grew 9.1% sequentially from ₹1,507.27 crore in Q1 FY26.
Q2FY26
|
Q1FY26
|
Q2FY25
|
QoQ
|
YoY
|
|
Rev
|
1643.79
|
1507.269
|
1366.682
|
9.1%
|
20.3%
|
EBITDA
|
426.493
|
360.743
|
332.332
|
18.2%
|
28.3%
|
EBITDA MARGINS
|
25.9%
|
23.9%
|
24.3%
|
8.4%
|
6.7%
|
Profit
|
258.829
|
196.051
|
199.293
|
32.0%
|
29.9%
|
Profitability also improved, with EBITDA jumping 28.3% YoY to ₹426.49 crore as against ₹332.33 crore a year earlier. On a sequential basis, EBITDA was up 18.2% from ₹360.74 crore.
EBITDA margin expanded to 25.9%, compared with 24.3% in Q2 FY25 and 23.9% in Q1 FY26.
The bottom line continued to show strong momentum. Net profit surged 29.9% YoY to ₹258.83 crore, from ₹199.29 crore a year earlier, and was 32% higher QoQ compared to ₹196.05 crore.
Looking ahead, the company said it plans to increase its bed capacity to over 7,650 by FY30, up from the current 5,750.
/images/ppid_59c68470-image-176335757392081941.webp)

/images/ppid_59c68470-image-176314252848455549.webp)

/images/ppid_59c68470-image-176309528074115989.webp)
/images/ppid_59c68470-image-176308510330420681.webp)
/images/ppid_59c68470-image-176310505866553496.webp)
/images/ppid_59c68470-image-176309264678289509.webp)
/images/ppid_59c68470-image-176310753861193740.webp)
/images/ppid_59c68470-image-176311504160031486.webp)
/images/ppid_59c68470-image-176309003334822777.webp)
/images/ppid_59c68470-image-176311003578995926.webp)